Researchers
Discover all researchers in life sciences
Loading researchers...
Vetriselvan Subramaniyan
Researcher at Research Department
Drug Discovery
Drug Solubulity And Delivery Systems
Eicosanoids And Hypertension Pharmacology
Natural Antidiabetic Agents Studies
Phytochemicals And Antioxidant Activities
591
Citations
13
H-index
0
Patents
51
Publications
0
Grants
$0
Total Funding
AI Research AssistantBeta
Ask questions about Vetriselvan Subramaniyan's research, publications, and ongoing work
What are their main research contributions?
Show me their collaboration network
What grants fund their research?
Research Contributions
Identified Long-Chain Non-coding RNAs as Key Players in Breast Cancer Signaling Pathways
Demonstrated the connection between long-chain non-coding RNAs and critical signaling pathways in breast cancer, providing potential therapeutic targets.
Pathology - Research and Practice (2023)
Elucidated the Role of MALAT1 in Lung Cancer Pathogenesis and Therapeutic Targeting
Identified MALAT1 as a key regulator in lung cancer development, suggesting new avenues for therapeutic intervention.
Pathology - Research and Practice (2023)
Developed Nanocarrier-Based Drug Delivery Systems for Natural Products in Breast Cancer Therapy
Engineered nanocarriers to deliver natural products effectively to treat breast cancer, enhancing drug efficacy and reducing side effects.
International Journal of Nanomedicine (2021)
Explored the Interplay of Traditional Medicine, Green Chemistry, and Biogenic Metallic Phytonanoparticles
Investigated the synergy between traditional medicine, green chemistry, and phytonanoparticles for modern healthcare innovation and sustainability.
Biomedicine & Pharmacotherapy (2023)
Evaluated Curcumin-Based Nanoformulations for Inflammatory Lung Diseases
Studied the therapeutic potential of curcumin-based nanoformulations as an emerging strategy for treating inflammatory lung diseases.
Future Medicinal Chemistry (2023)
Investigated the Role of CircRNAs in Modulating TGF-β Signaling in Cancer
Identified circRNAs as pivotal modulators of TGF-β signaling in cancer pathogenesis, offering insights into novel therapeutic approaches.
Non-coding RNA Research (2024)
Developed a Self-Nano Emulsifying Drug Delivery System (SNEDDS) for Ornidazole
Created a SNEDDS formulation to improve the solubility and oral bioavailability of Ornidazole, a BCS class II drug.
Scientific Reports (2024)
Examined the Neuroprotective Effects of Mangiferin in a Rat Model of Huntington's Disease
Demonstrated the neuroprotective potency of mangiferin against 3-nitropropionic acid-induced Huntington’s disease-like symptoms in rats, highlighting its antioxidant and anti-inflammatory mechanisms.
Frontiers in Pharmacology (2023)
Research Highlights
Professor Vetriselvan Subramaniyan is a distinguished pharmacologist at Sunway University, specializing in drug discovery, nanomedicine, and the therapeutic potential of natural products for treating cancer and inflammatory diseases. His research focuses on innovative drug delivery systems and computational approaches to identify novel therapeutic targets.
Research Areas
Drug DiscoveryDrug Solubulity And Delivery SystemsEicosanoids And Hypertension PharmacologyNatural Antidiabetic Agents StudiesPhytochemicals And Antioxidant Activities
Similar Researchers You Should Know
Researchers with overlapping expertise and complementary work
Finding similar researchers...